Genitourinary, Prostate Metastatic
Open, Temporarily Closed
CASPAR – A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Eligible for screening study DCP 001
A031902 is temporarily suspended to accrual, effective March 12, 2021.